KBC Life Sciences & Biotech Virtual Conference . Management will participate in investor meetings onTuesday, September 7, 2021 .Morgan Stanley Global Healthcare Conference . Fireside chat onFriday, September 10, 2021 at4:15 p.m. ET .BofA Global Healthcare Conference . Fireside chat onThursday, September 16, 2021 at4:45 p.m. BST .- SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event. Management will participate in investor meetings on
Wednesday, September 22, 2021 .
Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in
For further information, please contact:
Media:
kkirk@argenx.com
Joke Comijn (EU)
jcomijn@argenx.com
Investors:
bdelgiacco@argenx.com
mgreenblatt@argenx.com
Source: argenx SE
2021 GlobeNewswire, Inc., source